FDA Okays First Two-Drug Treatment for Melanoma

Published January 21, 2014

FDA Okays First Two-Drug Treatment For Melanoma
The first FDA approval for a two-drug treatment for melanoma, a deadly form of skin cancer, involves the combined treatment of Tafinlar (dabrafenib) and Mekinist (trametinib). Each drug, along with an approved diagnostic test, received FDA approval in …
Read more on Motley Fool

William Hitt on the Hitt Wellness Center Addiction and Cancer Treatment – News Coverage — Visit: http://www.hittwellnesscenter.com The Hitt wellness Center has 18 years experience specializing in immune building support for a wide variety of disea…

More Drug Treatment News Information…